Pledge generates $18 million for cancer research
Fred Eshelman may not have intended to
propel the Carolina First Campaign into the history books, but his $9 million
pledge to the School of Pharmacy did just that. The University
now has completed the fifth-largest campaign in higher education and the
largest at a southern university.
The board of North Carolina’s University Cancer Research
Fund matched the pledge, generating a total investment of $18 million. The
funds will support cancer research by the School of Pharmacy and the UNC
Lineberger Comprehensive Cancer Center that focuses on genetics, individualized
cancer therapy, drug discovery and drug delivery.
Calling the Eshelman pledge another great example of
public-private partnership,
Chancellor James Moeser said it also showed the significant impact of
leveraging
commitments from multiple sources.
“Dr. Eshelman’s support epitomizes what this campaign has
been all about,” Moeser said. “Carolina First truly transformed this
university. Every dollar has made us a stronger institution, and every donor
has our deepest gratitude.”
Eshelman is CEO and founder of
Wilmington-based PPD Inc., a global contract
research organization providing discovery,
development and post-approval services as well as compound partnering programs
to the
biopharmaceutical industry.
His latest pledge builds on his $20 million commitment to
the School of Pharmacy in 2003. That marked the largest commitment ever to a
U.S. pharmacy school.
Bob Blouin, dean of the School of Pharmacy, said that
Eshelman wanted to keep the school moving forward. He pointed to NIH funding
to the school as an example of its progress. In 2003, the school ranked 22nd
among the
nation’s pharmacy schools in NIH funding. Last year it had climbed to eighth.
“Thanks to the support of generous donors, our aggressive
pursuit of research funding and partners like Lineberger, we have had great
success in attracting really top-flight scientists to the school over the past
few years,” Blouin said.
“That kind of effort puts considerable strain on resources,
and we expected that it would take five years to have all our new centers
working at full capacity,” he said. “Dr. Eshelman wanted to significantly shorten
that time frame.”
Moeser said Eshelman’s commitment marked a “particularly
appropriate high note to go out on.” |